Sanofi Pasteur MSD appoints new UK medical director
pharmafile | August 17, 2011 | Appointment | Research and Development, Sales and Marketing |Â Â appointment, research and development, sales and marketingÂ
Sanofi Pasteur MSD has appointed Dr Aidrian Kilcoyne as medical director in the UK.
He joins the company from Roche Pharmaceuticals Ireland, where he managed a team responsible for medical affairs, pharmacovigilance, regulatory affairs, medical information and clinical research.
Before his time at Roche Aidrian held a medical director role at Baxter Healthcare, prior to which he had a served as a senior clinical research physician at Lilly.
A graduate of Trinity College, Dublin, he gained his master of public health at the London School of Hygiene and Tropical Medicine followed by an MBA from Warwick Business School.
Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …






